{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:40:50Z","timestamp":1747204850830,"version":"3.40.5"},"posted":{"date-parts":[[2023,7,17]]},"group-title":"In Review","reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,7,10]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n Pure autonomic failure (PAF) is a rare disease characterized clinically by neurogenic orthostatic hypotension (nOH) and biochemically by peripheral noradrenergic deficiency. Clinically diagnosed PAF can evolve (\u201cphenoconvert\u201d) to a central Lewy body disease (LBD, e.g., Parkinson\u2019s disease (PD) or dementia with Lewy bodies (DLB)) or to the non-LBD synucleinopathy multiple system atrophy (MSA). We examined whether cardiac <sup>18<\/sup>F-dopamine positron emission tomography (PET) predicts the trajectory of phenoconversion in PAF. Since cardiac <sup>18<\/sup>F-dopamine-derived radioactivity always is decreased in LBDs with nOH and usually is normal in MSA, we hypothesized that PAF patients with low cardiac <sup>18<\/sup>F-dopamine-derived radioactivity may phenoconvert to a central LBD but do not phenoconvert to MSA.\nMethods\n We reviewed data from all the patients seen at the National Institutes of Health Clinical Center from 1994 to 2023 with a clinical diagnosis of PAF and data about serial <sup>18<\/sup>F-dopamine PET.\nResults\n Twenty patients met the above criteria. Of 15 with low cardiac <sup>18<\/sup>F-dopamine-derived radioactivity, 6 (40%) phenoconverted to PD or DLB and none to MSA. Of 5 patients with consistently normal <sup>18<\/sup>F-dopamine PET, 4 phenoconverted to MSA, and the other at autopsy had neither a central LBD nor MSA.\nConclusion\n In this case series, 40% of patients with nOH and low cardiac <sup>18<\/sup>F-dopamine-derived radioactivity phenoconverted to PD or DLB during follow-up; none phenoconverted to MSA. Cardiac <sup>18<\/sup>F-DA PET therefore can predict the type of phenoconversion in PAF. This capability could refine eligibility criteria for entry into disease-modification trials aiming to prevent evolution of PAF to symptomatic central LBDs.<\/p>","DOI":"10.21203\/rs.3.rs-3157807\/v1","type":"posted-content","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T14:13:26Z","timestamp":1689603206000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiac 18F-Dopamine Positron Emission Tomography Predicts the Type of Phenoconversion of Pure Autonomic Failure"],"prefix":"10.21203","author":[{"given":"Abhishek","family":"Lenka","sequence":"first","affiliation":[{"name":"Baylor College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Isonaka","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke Intramural Research Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Holmes","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke Intramural Research Program"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5709-9940","authenticated-orcid":false,"given":"David S.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"National Institute of Neurological Disorders and Stroke Intramural Research Program"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0002-8703(25)90007-5","article-title":"Postural hypotension: A report of three cases","volume":"1","author":"Bradbury S","year":"1925","unstructured":"Bradbury S, Eggleston C (1925) Postural hypotension: A report of three cases. Am Heart J 1:73\u201386","journal-title":"Am Heart J"},{"year":"2021","author":"Chia R","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, Hernandez DG, Blauwendraat C, Stone DJ, Eicher J, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, St George-Hyslop P, Londos E, Morgan K, Lashley T, Warner TT, Jaunmuktane Z, Galasko D, Santana I, Tienari PJ, Myllykangas L, Oinas M, Cairns NJ, Morris JC, Halliday GM, Van Deerlin VM, Trojanowski JQ, Grassano M, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Brett F, Gan-Or Z, Geiger JT, Moore A, May P, Kruger R, Goldstein DS, Lopez G, Tayebi N, Sidransky E, American Genome C, Norcliffe-Kaufmann L, Palma JA, Kaufmann H, Shakkottai VG, Perkins M, Newell KL, Gasser T, Schulte C, Landi F, Salvi E, Cusi D, Masliah E, Kim RC, Caraway CA, Monuki ES, Brunetti M, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Flanagan ME, Mao Q, Bigio EH, Rodriguez-Rodriguez E, Infante J, Lage C, Gonzalez-Aramburu I, Sanchez-Juan P, Ghetti B, Keith J, Black SE, Masellis M, Rogaeva E, Duyckaerts C, Brice A, Lesage S, Xiromerisiou G, Barrett MJ, Tilley BS, Gentleman S, Logroscino G et al (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53:294\u2013303","key":"ref2"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1212\/WNL.0000000000010002","article-title":"Predicting phenoconversion in pure autonomic failure","volume":"95","author":"Coon EA","year":"2020","unstructured":"Coon EA, Mandrekar JN, Berini SE, Benarroch EE, Sandroni P, Low PA, Singer W (2020) Predicting phenoconversion in pure autonomic failure. Neurology 95:e889\u2013e897","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11910-022-01171-0","article-title":"Predictors of RBD progression and conversion to synucleinopathies","volume":"22","author":"Natale ER","year":"2022","unstructured":"de Natale ER, Wilson H, Politis M (2022) Predictors of RBD progression and conversion to synucleinopathies. Curr Neurol Neurosci Rep 22:93\u2013104","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/jnnp-2011-301817","article-title":"Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia","volume":"84","author":"Tredici K","year":"2013","unstructured":"Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia. J Neurol Neurosurg Psychiatry 84:774\u2013783","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref6","article-title":"Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb","author":"Dickson DW","year":"2012","unstructured":"Dickson DW (2012) Parkinson's disease and parkinsonism: neuropathology. Cold Spring Harb. Perspect Med 2","journal-title":"Perspect Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10286-018-0581-4","article-title":"Skin nerve alpha-synuclein deposits in Parkinson's disease and other synucleinopathies: a review","volume":"29","author":"Donadio V","year":"2019","unstructured":"Donadio V (2019) Skin nerve alpha-synuclein deposits in Parkinson's disease and other synucleinopathies: a review. Clin Auton Res 29:577\u2013585","journal-title":"Clin Auton Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"14246","DOI":"10.1038\/s41598-018-32588-8","article-title":"Skin alpha-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study","volume":"8","author":"Donadio V","year":"2018","unstructured":"Donadio V, Incensi A, El-Agnaf O, Rizzo G, Vaikath N, Del Sorbo F, Scaglione C, Capellari S, Elia A, Stanzani Maserati M, Pantieri R, Liguori R (2018) Skin alpha-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study. Sci Rep 8:14246","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mds.28126","article-title":"Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension","volume":"35","author":"Donadio V","year":"2020","unstructured":"Donadio V, Incensi A, Rizzo G, De Micco R, Tessitore A, Devigili G, Del Sorbo F, Bonvegna S, Infante R, Magnani M, Zenesini C, Vignatelli L, Cilia R, Eleopra R, Tedeschi G, Liguori R (2020) Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension. Mov Disord 35:1649\u20131657","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/brain\/awac124","article-title":"Phosphorylated alpha-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy","volume":"146","author":"Donadio V","year":"2023","unstructured":"Donadio V, Incensi A, Rizzo G, Westermark GT, Devigili G, De Micco R, Tessitore A, Nyholm D, Parisini S, Nyman D, Tedeschi G, Eleopra R, Ingelsson M, Liguori R (2023) Phosphorylated alpha-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy. Brain 146:1065\u20131074","journal-title":"Brain"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1093\/brain\/awab236","article-title":"Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease","volume":"144","author":"Doppler CEJ","year":"2021","unstructured":"Doppler CEJ, Kinnerup MB, Brune C, Farrher E, Betts M, Fedorova TD, Schaldemose JL, Knudsen K, Ismail R, Seger AD, Hansen AK, Staer K, Fink GR, Brooks DJ, Nahimi A, Borghammer P, Sommerauer M (2021) Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease. Brain 144:2732\u20132744","journal-title":"Brain"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-444-53480-4.00006-0","article-title":"Diabetic autonomic neuropathy","volume":"126","author":"Freeman R","year":"2014","unstructured":"Freeman R (2014) Diabetic autonomic neuropathy. Handb Clin Neurol 126:63\u201379","journal-title":"Handb Clin Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman R","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69\u201372","journal-title":"Clin Auton Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e1245","DOI":"10.1212\/WNL.0000000000006243","article-title":"The natural history of idiopathic autonomic failure: The IAF-BO cohort study","volume":"91","author":"Giannini G","year":"2018","unstructured":"Giannini G, Calandra-Buonaura G, Asioli GM, Cecere A, Barletta G, Mignani F, Ratti S, Guaraldi P, Provini F, Cortelli P (2018) The natural history of idiopathic autonomic failure: The IAF-BO cohort study. Neurology 91:e1245\u2013e1254","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein DS","year":"2008","unstructured":"Goldstein DS, Holmes C, Bentho O, Sato T, Moak J, Sharabi Y, Imrich R, Conant S, Eldadah BA (2008) Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord 14:600\u2013607","journal-title":"Parkinsonism Relat Disord"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM199703063361004","article-title":"Sympathetic cardioneuropathy in dysautonomias","volume":"336","author":"Goldstein DS","year":"1997","unstructured":"Goldstein DS, Holmes C, Cannon RO 3rd, Eisenhofer G, Kopin IJ (1997) Sympathetic cardioneuropathy in dysautonomias. N Engl J Med 336:696\u2013702","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autneu.2008.12.004","article-title":"Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations","volume":"146","author":"Goldstein DS","year":"2009","unstructured":"Goldstein DS, Holmes C, Imrich R (2009) Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations. Auton Neurosci 146:18\u201321","journal-title":"Auton Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","article-title":"Cardiac sympathetic denervation in Parkinson disease","volume":"133","author":"Goldstein DS","year":"2000","unstructured":"Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO 3rd (2000) Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med 133:338\u2013347","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.parkreldis.2017.10.003","article-title":"Cardiac sympathetic denervation predicts PD in at-risk individuals","volume":"52","author":"Goldstein DS","year":"2018","unstructured":"Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y (2018) Cardiac sympathetic denervation predicts PD in at-risk individuals. Parkinsonism Relat Disord 52:90\u201393","journal-title":"Parkinsonism Relat Disord"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.parkreldis.2018.02.023","article-title":"Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease","volume":"50","author":"Goldstein DS","year":"2018","unstructured":"Goldstein DS, Holmes C, Lopez GJ, Wu T, Sharabi Y (2018) Cerebrospinal fluid biomarkers of central dopamine deficiency predict Parkinson's disease. Parkinsonism Relat Disord 50:108\u2013112","journal-title":"Parkinsonism Relat Disord"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/aws055","article-title":"Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies","volume":"135","author":"Goldstein DS","year":"2012","unstructured":"Goldstein DS, Holmes C, Sharabi Y (2012) Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. Brain 135:1900\u20131913","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1212\/01.WNL.0000058766.46428.F3","article-title":"Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension","volume":"60","author":"Goldstein DS","year":"2003","unstructured":"Goldstein DS, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G (2003) Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension. Neurology 60:1327\u20131332","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1212\/WNL.0000000000002086","article-title":"Survival in synucleinopathies: A prospective cohort study","volume":"85","author":"Goldstein DS","year":"2015","unstructured":"Goldstein DS, Holmes C, Sharabi Y, Wu T (2015) Survival in synucleinopathies: A prospective cohort study. Neurology 85:1554\u20131561","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02291401","article-title":"Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome","volume":"6","author":"Goldstein DS","year":"1996","unstructured":"Goldstein DS, McRae A, Holmes C, Dalakas MC (1996) Autoimmune autonomic failure in a patient with myeloma-associated Shy-Drager syndrome. Clin Auton Res 6:17\u201321","journal-title":"Clin Auton Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainres.2017.09.033","article-title":"The heart of PD: Lewy body diseases as neurocardiologic disorders","volume":"1702","author":"Goldstein DS","year":"2019","unstructured":"Goldstein DS, Sharabi Y (2019) The heart of PD: Lewy body diseases as neurocardiologic disorders. Brain Res 1702:74\u201384","journal-title":"Brain Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/jnc.15371","article-title":"Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies","volume":"158","author":"Goldstein DS","year":"2021","unstructured":"Goldstein DS, Sullivan P, Holmes C, Lamotte G, Lenka A, Sharabi Y (2021) Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies. J Neurochem 158:554\u2013568","journal-title":"J Neurochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02281111","article-title":"Non-invasive detection of sympathetic neurocirculatory failure","volume":"10","author":"Goldstein DS","year":"2000","unstructured":"Goldstein DS, Tack C (2000) Non-invasive detection of sympathetic neurocirculatory failure. Clin Auton Res 10:285\u2013291","journal-title":"Clin Auton Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"105626","DOI":"10.1016\/j.nbd.2022.105626","article-title":"Clinical and imaging evidence of brain-first and body-first Parkinson's disease","volume":"164","author":"Horsager J","year":"2022","unstructured":"Horsager J, Knudsen K, Sommerauer M (2022) Clinical and imaging evidence of brain-first and body-first Parkinson's disease. Neurobiol Dis 164:105626","journal-title":"Neurobiol Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10286-019-00644-6","article-title":"Association of innervation-adjusted alpha-synuclein in arrector pili muscles with cardiac noradrenergic deficiency in autonomic synucleinopathies","volume":"29","author":"Isonaka R","year":"2019","unstructured":"Isonaka R, Gibbons CH, Wang N, Freeman R, Goldstein DS (2019) Association of innervation-adjusted alpha-synuclein in arrector pili muscles with cardiac noradrenergic deficiency in autonomic synucleinopathies. Clin Auton Res 29:587\u2013593","journal-title":"Clin Auton Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10286-017-0404-z","article-title":"Pure autonomic failure without synucleinopathy","volume":"27","author":"Isonaka R","year":"2017","unstructured":"Isonaka R, Holmes C, Cook GA, Sullivan P, Sharabi Y, Goldstein DS (2017) Pure autonomic failure without synucleinopathy. Clin Auton Res 27:97\u2013101","journal-title":"Clin Auton Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/HYPERTENSIONAHA.118.12642","article-title":"Alpha-Synuclein deposition within sympathetic noradrenergic neurons is associated with myocardial noradrenergic deficiency in neurogenic orthostatic hypotension","volume":"73","author":"Isonaka R","year":"2019","unstructured":"Isonaka R, Rosenberg AZ, Sullivan P, Corrales A, Holmes C, Sharabi Y, Goldstein DS (2019) Alpha-Synuclein deposition within sympathetic noradrenergic neurons is associated with myocardial noradrenergic deficiency in neurogenic orthostatic hypotension. Hypertension 73:910\u2013918","journal-title":"Hypertension"},{"issue":"Suppl 6","key":"ref32","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.10557","article-title":"Neuropathological spectrum of synucleinopathies","volume":"18","author":"Jellinger KA","year":"2003","unstructured":"Jellinger KA (2003) Neuropathological spectrum of synucleinopathies. Mov Disord 18(Suppl 6):S2\u201312","journal-title":"Mov Disord"},{"key":"ref33","article-title":"Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia","author":"Jellinger KA","year":"2023","unstructured":"Jellinger KA (2023) Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia. J Neural Transm (Vienna)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02291236","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy","volume":"6","author":"Kaufmann H","year":"1996","unstructured":"Kaufmann H (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 6:125\u2013126","journal-title":"Clin Auton Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ana.24877","article-title":"Natural history of pure autonomic failure: A United States prospective cohort","volume":"81","author":"Kaufmann H","year":"2017","unstructured":"Kaufmann H, Norcliffe-Kaufmann L, Palma JA, Biaggioni I, Low PA, Singer W, Goldstein DS, Peltier AC, Shibao CA, Gibbons CH, Freeman R, Robertson D (2017) Natural history of pure autonomic failure: A United States prospective cohort. Ann Neurol 81:287\u2013297","journal-title":"Ann Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.parkreldis.2019.09.014","article-title":"Long-term trends in myocardial sympathetic innervation and function in synucleinopathies","volume":"67","author":"Lamotte G","year":"2019","unstructured":"Lamotte G, Holmes C, Wu T, Goldstein DS (2019) Long-term trends in myocardial sympathetic innervation and function in synucleinopathies. Parkinsonism Relat Disord 67:27\u201333","journal-title":"Parkinsonism Relat Disord"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/mdc3.13190","article-title":"Cardiac (18)F-dopamine PET distinguishes PD with orthostatic hypotension from Parkinsonian MSA","volume":"8","author":"Lenka A","year":"2021","unstructured":"Lenka A, Lamotte G, Goldstein DS (2021) Cardiac (18)F-dopamine PET distinguishes PD with orthostatic hypotension from Parkinsonian MSA. Mov Disord Clin Pract 8:582\u2013586","journal-title":"Mov Disord Clin Pract"},{"key":"ref38","first-page":"1","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"Neurology","author":"Nalls MA","year":"2013","unstructured":"Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E (2013) A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurology:1\u20139","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-28-4-723","article-title":"Studies on the circulation with the aid of tagged erythrocytes in a case of orthostatic hypotension (asympathicotonic hypotension)","volume":"28","author":"Nylin G","year":"1948","unstructured":"Nylin G, Levander M (1948) Studies on the circulation with the aid of tagged erythrocytes in a case of orthostatic hypotension (asympathicotonic hypotension). Ann Intern Med 28:723\u2013746","journal-title":"Ann Intern Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10286-019-00623-x","article-title":"Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management","volume":"29","author":"Palma JA","year":"2019","unstructured":"Palma JA, Gonzalez-Duarte A, Kaufmann H (2019) Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management. Clin Auton Res 29:33\u201344","journal-title":"Clin Auton Res"},{"key":"ref41","article-title":"Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder","author":"Park DG","year":"2023","unstructured":"Park DG, Kim JY, Kim MS, Kim MH, An YS, Chang J, Yoon JH (2023) Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder. J Neurol","journal-title":"J Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF00314991","article-title":"Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report","volume":"41","author":"Senard JM","year":"1991","unstructured":"Senard JM, Arias A, Berlan M, Tran MA, Rascol A, Montastruc JL (1991) Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report. Eur J Clin Pharmacol 41:593\u2013596","journal-title":"Eur J Clin Pharmacol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.25824","article-title":"Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies","volume":"88","author":"Singer W","year":"2020","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Boeve BF, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Savica R, Suarez MD, Soto C, Low PA (2020) Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies. Ann Neurol 88:503\u2013512","journal-title":"Ann Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/ana.26089","article-title":"Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure","volume":"89","author":"Singer W","year":"2021","unstructured":"Singer W, Schmeichel AM, Shahnawaz M, Schmelzer JD, Sletten DM, Gehrking TL, Gehrking JA, Olson AD, Suarez MD, Misra PP, Soto C, Low PA (2021) Alpha-Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure. Ann Neurol 89:1212\u20131220","journal-title":"Ann Neurol"},{"year":"1998","author":"Spillantini MG","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95:6469\u20136473","key":"ref45"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini MG","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi K","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180\u2013182","journal-title":"Neurosci Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning GK","year":"1994","unstructured":"Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1994) Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117:835\u2013845","journal-title":"Brain"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM197702102960601","article-title":"The sympathetic-nervous-system defect in primary orthostatic hypotension","volume":"296","author":"Ziegler MG","year":"1977","unstructured":"Ziegler MG, Lake CR, Kopin IJ (1977) The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 296:293\u2013297","journal-title":"N Engl J Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3157807\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3157807\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:29:25Z","timestamp":1698074965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3157807\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":49,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3157807\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s10286-023-00987-1","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2023,7,17]]},"subtype":"preprint"}}